Molly Henderson
2019 - Advaxis
In 2019, Molly Henderson earned a total compensation of $596.4K as Executive VP, Chief Financial Officer at Advaxis.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $58,498 |
| Salary | $397,896 |
| Other | $20,052 |
| Total | $596,446 |
Henderson received $397.9K in salary, accounting for 67% of the total pay in 2019.
Henderson also received $120K in bonus, $58.5K in option awards and $20.1K in other compensation.
Rankings
In 2019, Molly Henderson's compensation ranked 11,226th out of 13,971 executives tracked by ExecPay. In other words, Henderson earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,226 out of 13,971 | 20th |
Division Manufacturing | 4,536 out of 5,692 | 20th |
Major group Chemicals And Allied Products | 1,779 out of 2,189 | 19th |
Industry group Drugs | 1,530 out of 1,875 | 18th |
Industry Pharmaceutical Preparations | 1,130 out of 1,387 | 19th |
Source: SEC filing on April 21, 2021.
Henderson's colleagues
We found two more compensation records of executives who worked with Molly Henderson at Advaxis in 2019.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
Advaxis CEO Kenneth Berlin's 2020 pay jumps 21% to $1.2M
April 21, 2021